This multi centre open label single arm non randomized observational study will compare the efficacy in terms of overall response rate and progression free survival of tamoxifen as first line therapy in 3 groups of postmenopausal women with measurable hormone dependent large, locally advanced or metastatic breast cancer <a href=https://lasix.autos/>lasix for pneumonia</a> Interestingly, upon increasing concentrations of VX 11E, slight increase in phosphorylated ERK1 2 is observed in the T 47D Tam clones
